Lee Radosh, M.D.

32% fewer Medicare Part D claims than the average addiction medicine (family medicine) physician in 2024

451 Medicare Part D claims for 71 beneficiaries, against an average of 664 among the 581 providers of this specialty who prescribed in Part D. Brand-name drugs were 19% of claims. 14 claims were for opioids.

Most prescribed

1. Buprenorphine-Naloxone218 claims
2. Sublocade58 claims
3. Naltrexone Hcl18 claims
4. Buprenorphine Hcl17 claims
5. Gabapentin17 claims
6. Suboxone15 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 81.2 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $27.03

1 payment: food and beverage; the largest payer was Indivior Inc. The 305 providers of this specialty with any payment received $1,151.00 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through 2 group practices

1. Ophelia Medical Group FL PAPhiladelphia, PA
2. Tower Health Medical GroupWyomissing, PA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).